Antitumor activity of combretastatin-A4 phosphate, a natural product tubulin inhibitor

Investigational New Drugs

Volumn 14, Issue 2, 1996, Pages 131-137

  Dorr, Robert T ^a,d   Dvorakova, Katerina ^a   Snead, Kristi ^a,b   Alberts, David S ^a   Salmon, Sydney E ^a   Pettit, G Robert ^c  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c ARIZONA STATE UNIVERSITY   (United States)

^d UNIVERSITY OF ARIZONA   (United States)

Author keywords

Antitumor agent; Combretastatin; Microtubule inhibition; Protein binding

Indexed keywords

ALBUMIN; ANTINEOPLASTIC AGENT; COMBRETASTATIN A4; MITOMYCIN; PLASMA PROTEIN; TUBULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; COLON CANCER; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CYTOTOXICITY; DRUG PROTEIN BINDING; HUMAN; HUMAN CELL; INTRAPERITONEAL DRUG ADMINISTRATION; LEUKEMIA; LEUKEMIA P 388; MALE; MELANOMA; MOUSE; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; TUMOR GROWTH; UTERINE CERVIX CANCER;

EID: 0029800934     PISSN: 01676997     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00210783     Document Type: Article

References (20)

1. Pettit GR, Singh SB, Niven ML, Hamel E, Schmidt JM: Isolation, structure, and synthesis of combretastatins A-1 and B-1, potent new inhibitors of microtubule assembly, derived from Combretum caffrum. J Nat Prod 50(1): 119-131, 1987
2. Pettit GR, Singh SB, Niven ML, Schmidt JM: Cell growth inhibitory dihydrophenanthrene and phenanthrene constituents of the African tree Combretum caffrum. Can J Chem 66:406-413, 1988
3. Hamel E, Ho HH, Kang GJ, Lin CM: Cornigerine, a potent antimitotic Colchicum alkaloid of unusual structure: interactions with tubulin. Biochem Pharmacol 37:2445-2449, 1988
4. Pettit GR, Singh SB, Hamel E, Lin CM, Alberts DS, Garcia-Kendall D: Isolation and structure of the strong cell growth and rubulin inhibitor combretastatin A-4. Experientia 45:209-211, 1989
5. McGown AT, Fox BW: Differential cytotoxicity of combretastatins A-l and A-4 in two daunorubicin-resistant P388 cell lines. Cancer Chemother Pharmacol 26:79-81, 1990
6. El-Zayat AAE, Degen D, Drabek S, Clark GM, Pettit GR, Von Hoff DD: In vitro evaluation of the antineoplastic activity of combretastatin A-4, a natural product from Combretum caffrum (arid shrub). Anti-Cancer Drugs 4:19-25, 1993
7. Hamburger A, Salmon SE: Primary bioassay of human myeloma stem cells. Science 197:461-463, 1977
8. Salmon SE, Hamburger AW, Soehnlen B, Durie BG, Alberts DS, Moon TE: Quantitation of differential sensitivity of human tumor stem cells to anticancer drugs. N Engl J Med 298:1321-1327, 1978
9. Salmon SE, Liu RM, Casazza AM: Evaluation of new anthracycline analogs with the human tumor stem cell assay. Cancer Chemother Pharmacol 6(2):103-109, 1981
10. Salmon SE, Young L, Lebowitz J, Thomson S, Einsphar J, Tong T, Moon TE: Evaluation of an automated image analysis system for counting human tumor colonies. Intl J Cell Cloning 2:142-160, 1984
11. Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Meth 65:55-63, 1983
12. Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren JT, Bokesch H, Kenney S, Boyd MR: New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 82:1107-1112, 1990
13. Griswold DP Jr: Consideration of the subcutaneously implanted B16 melanoma as a screening model for potential anticancer agents. Cancer Chemother Rep 3(Part 2, No. 1):315-324, 1972
14. Corbett TH, Griswold DP Jr, Roberts BJ, Peckham JC, Schabel FM Jr: Biology and therapeutic response of a mouse mammary adenocarcinoma (16/C) and its potential as a model for surgical adjuvant chemotherapy. Cancer Treat Rep 62(10): 1471-1488, 1978
15. Gehan E A: A generalized Wilcoxon test for comparing arbitrarily single-censored samples. Biometrika 52:203-210, 1965
16. Jackson DV, Bender RA: Cytotoxic thresholds of vincristine in L1210 murine leukemia and a human lymphoblastic cell line in vitro. Cancer Res 39:4346-4349, 1979
17. Cahan MA, Walter KA, Colvin OM, Brem H: Cytotoxicity of taxol in vitro against human and rat malignant brain tumors. Cancer Chemother Pharmacol 33:441-444, 1994
18. Georgiadis MS, Russell E, Johnson BE: Prolonging the exposure of human lung cancer cell lines to paclitaxel improves the cytotoxicity. Proc Am Assoc Cancer Res 35:341, 1994
19. Johnson IS, Armstrong JG, Gorman M, Burnett JP Jr: The vinca alkaloids: a new class of oncolytic agents. Cancer Res 23:1390-1427, 1963
20. National Cancer Institute Clinical Brochure; Taxol (NSC-125973). Division of Cancer Treatment, N.C.I., Bethesda, MD, Sept. 1983, pp 6-12